TNF Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-30. The offering totals $7.4M. Industry: Other Health Care.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Chris Chapman | Director | BALTIMORE, MD |
| Bill White | Director | San Jose, CA |
| Adam Kaplin | Executive Officer | Baltimore, MD |
| Paul Rivard | Executive Officer | Baltimore, MD |
| Joshua Silverman | Director | NEW YORK, NY |
| Joshua Silverman | Executive Officer | NEW YORK, NY |
| BRUCE BERNSTEIN | Director | Miami, FL |
| Christopher Schreiber | Director | New York, NY |
| Ian Rhodes | Executive Officer | New York, NY |
| Mitchell J Glass | Director | New York, NY |
| Mitchell J Glass | Executive Officer | New York, NY |
| Stephen J Friscia | Director | New York, NY |
| Bill J White | Director | New York, NY |
| Chris Chapman | Executive Officer | BALTIMORE, MD |
| Jude Uzonwanne | Director | BALTIMORE, MD |
| Craig Eagle | Director | Grasonville, MD |
| Thomas Knox | Director | Baltimore, MD |
| Joshua C Silverman | Director | Round Rock, TX |
| Stuart Benson | Executive Officer | Thorofare, NJ |
| Christopher C Schreiber | Director | Thorofare, NJ |
| Christopher C Schreiber | Executive Officer | Thorofare, NJ |
| Howard Yeaton | Executive Officer | Thorofare, NJ |
| Raymond Akers | Director | THOROFARE, NJ |
| Raymond Akers | Executive Officer | THOROFARE, NJ |
| Brandon Knox | Director | THOROFARE, NJ |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-09-05 | D | $7.0M | $7.0M |
| 2024-05-31 | D | $15.2M | $15.2M |
| 2024-05-31 | D | $26.9M | $26.9M |
| 2020-11-24 | D | $18.1M | $18.1M |
| 2020-08-11 | D | — | — |
| 2020-05-21 | D | $482K | $482K |
| 2020-04-14 | D | $460K | $460K |
| 2020-04-07 | D | $2.7M | $1.2M |
| 2017-04-13 | D | $2.0M | $2.0M |